Pharma Journalist -

U.S Stem Cell, Inc. claimed to be a leader in the development of proprietary stem cell therapies asserted accomplishing the target of 10,000 kit sales of proprietary Adipocell product,…
Read More...

Global biotech company committed to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, Castle Creek Pharmaceuticals confirmed…
Read More...

U.S FDA approves Teva Pharmaceutical's TRISENOX i.e. Arsenic trioxide injection amalgamated with  tretinoin  in the therapy of adults diagnosed with low -risk acute promyelocytic…
Read More...

SMi's ADC conference will be bringing a global presence from Pfizer, Genentech, Ablynx, Spirogen, Seattle Genetics, Medimmune, Antikor Biopharma, Heidelberg Pharma and more. With an…
Read More...

Biopharmaceutical Company, Amcure insisted on extending its team of members by further appointing  Heinz Dieter Schwer, PhD, MBA, CEO of ViraTherapeutics. Klaus Dembowsky, MD, PhD,…
Read More...

SMi’s Superbugs &Superdrugs Conference 2018 will gather a high level of international experts and project decision makers to review the successes of 2017 and look to the future of…
Read More...

Adaptimmune Therapeutics embarks on manufacturing T-cell therapy to treat  cancer entitled SPEAR T-cells for a patient at its Navy Yard facility in Philadelphia. In addition to this…
Read More...

Celgene Corporation and Impact Biomedicinessigned and agreement that entails acquisition of Impact Biomedicines enabling development of fedratinib  for myelofibrosis and polycythemia…
Read More...

Following the league of leading in the markets of  clinical research organizations, Optimapharm obtained Czech CRO company MKS research. Following the acquisition , Optimapharm will…
Read More...

Ipsen declared the appointment of Richard Paulson as Executive Vice-president and Chief Executive Officer of Ipsen North America accountable for  commercial operations throughout the…
Read More...